Prestige Biologics Co (XKRX:334970) Interest Expense : ₩-11,849 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Prestige Biologics Co's interest expense for the three months ended in Dec. 2024 was ₩ -3,036 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-11,849 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Prestige Biologics Co's Operating Income for the three months ended in Dec. 2024 was ₩ -12,914 Mil. Prestige Biologics Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -3,036 Mil. Prestige Biologics Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Prestige Biologics Co Interest Expense Historical Data

The historical data trend for Prestige Biologics Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Biologics Co Interest Expense Chart

Prestige Biologics Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Jun23

Jun24

Interest Expense

Get a 7-Day Free Trial

-2,900.36

-763.51

-3,928.64

-3,525.25

-11,768.60

Prestige Biologics Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-2,645.02	-3,230.71	-3,323.38	-2,258.94	-3,035.51

Prestige Biologics Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-11,849 Mil.

Prestige Biologics Co (XKRX:334970) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Prestige Biologics Co's Interest Expense for the three months ended in Dec. 2024 was ₩-3,036 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-12,914 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩38,111 Mil.

Prestige Biologics Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Prestige Biologics Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Prestige Biologics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161

Website

https://www.prestigebiologics.com

Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co Headlines

No Headlines